对转移性或复发性阴茎癌的后续线系统疗法:有效性,毒性和结果的系统性审查
Radion Garaz1, Mahmoud Ziada2, Jack Crozier2
1Department of Urology, University Hospital Tübingen, Tübingen, Germany; Male Genital Cancer Center, Department of Urology, University College London Hospitals NHS Foundation Trust, London, UK.
European urology focus
|January 10, 2026
概括
在初始化疗后,晚期阴茎癌的全身治疗方法有限. 针对性疗法和免疫疗法在生物标志物选择的患者中表现有前途,但需要更多的研究.
科学领域:
- 在瘤学瘤学.
- 医学研究 医学研究
背景情况:
- 阴茎状细胞癌 (PSCC) 是一种罕见的恶性瘤.
- 在一线基化疗后,转移或复发的PSCC存在有限的治疗选择.
研究的目的:
- 系统地审查转移性或复发性PSCC的第二线和后一线全身治疗的疗效,安全性和生存结果.
主要方法:
- 对包括367名患者在内的17项研究 (非随机试验和病例系列) 的系统综述.
- 在多个数据库 (PubMed,Scopus,Embase等) 进行了搜索. 在2025年6月之前.
- 主要结局:总生存率 (OS) 和无进展生存率 (PFS).
主要成果:
- 证据质量较低,原因是小队列和异质性.
- 平均生存期在4.3至9.5个月之间;平均PFS在1.3至4.8个月之间.
- 向疗法显示有利的OS和较低的3-4级不良事件,其次是免疫疗法和化疗. 观察到由生物标志物驱动的益处.
结论:
- 对于转移性或复发性PSCC,除了第一线治疗之外,还没有标准的全身疗法.
- 向药物和免疫检查点抑制剂在生物标志物选择的子组中表现出活性.
- 未来的生物标志物引导试验和国际合作对于这种罕见的癌症至关重要.
相关概念视频
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K


